Cite

HARVARD Citation

    Falsey, A. et al. (n.d.). Safety and Tolerability of an Ad26.RSV.preF-based Vaccine in a Phase 2b Study in Older Adults. Innovation in aging. p. 1054. [Online]. 
  
Back to record